Clinical Trial Update: Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rifaximin for chronic intestinal pseudo-obstruction to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Pseudo-obstruction

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Yokohama City University | Conditions: Chronic Intestinal Pseudo-obstruction | Phase 2 | Status: UNKNOWN